Skip to main content
Journals

Global Insights Into Confidence and Self-Perception in Aesthetic Medicine: A 15-Country Survey Analysis

Aesthetic Surgery Journal Open Forum
Aesthetic Surgery Journal Open Forum

Authors: Shannon Humphrey, MD , Claudia Andrea Hernández, MD , Jose Raul Montes, MD , Je-Young Park, MD , Daria Voropai, MBBS, BDS , Katherine Warnell, PhD

Abstract: Nonsurgical aesthetic treatments have been found to improve patient confidence; however, the interplay between patient attitudes and aesthetic treatment experiences is not fully understood. The aim of this study was to further characterize the role of confidence and self-perception in the decision to pursue aesthetic treatments and in patient experience of outcomes. A total of 15,155 adults from 15 countries were recruited to participate in a device-agnostic online survey. Qualified participants were adults 21 to 75 years of age who had an aesthetic treatment in the past 12 months or would consider one in the next 24 months. Respondents reported a mismatch between their inner self and outward appearance, which may influence self-perception and social interactions. Individuals viewed aesthetic treatments as more than appearance enhancements, and many considered aesthetic treatments to be acts of self-care and empowerment, integrating them into their regular beauty routines. The strongest influence on individuals’ self-image was close personal relationships, whereas societal norms and social media played a secondary role. Results suggest that confidence derived through aesthetic treatments can shape self-perception and social well-being; moreover, the decision to obtain aesthetic treatment is not at odds with self-confidence and can be an empowering experience.

JOURNAL ARTICLE

Related Articles

Upper facial lines (UFLs), including glabellar frown lines (GFLs), horizontal forehead lines (HFLs), and lateral canthal lines (LCLs) are prevalent aesthetic concerns addressed with botulinum neurotoxin type A (BoNT-A). IncobotulinumtoxinA, a highly purified BoNT-A formulation, is utilized for simultaneous UFLs treatment; yet, comprehensive synthesized evidence is limited.
Collagenase clostridium histolyticum-aaes (CCH-aaes) is FDA-approved for cellulite treatment but was withdrawn because of high bruising incidence. Histological effects of CCH-aaes in humans remain poorly characterized. The aim of the study was to evaluate histopathologic changes in human subcutaneous tissue following CCH-aaes injection and compare injection techniques to identify strategies that reduce bruising.
Botulinum neurotoxin A (BoNT-A) is widely used clinically; yet, its temporary effects require repeated injections that increase cost and inconvenience. There is limited rigorous evidence to support claims that repeated BoNT-A use alters efficacy. Unlike peripheral nerve transection, which causes irreversible denervation after 12 to 24 months, the long-term physiological effects of BoNT-A chemodenervation remain unclear.